OBJECTIVES: To identify predictive factors and assess the impact on oncological outcomes of intravesical recurrence after radical nephroureterectomy (RNU) in upper tract urothelial carcinoma (UTUC). METHODS: Using a national multicentric retrospective dataset, we identified all patients with UTUC who underwent a RNU between 1995 and 2010 (n = 482). Intravesical recurrence was tested as a prognostic factor for survival through univariable and multivariable Cox regression analysis. RESULTS: Overall, intravesical recurrence occurred in 169 patients (35 %) with a median age of 69.2 years (IQR: 60-76) and after a median follow-up of 39.5 months (IQR: 25-60). Actuarial intravesical recurrence-free survival estimates at 2 and 5 years after RNU were 72 and 45 %, respectively. On univariable analyses, previous history of bladder tumor, tumor multifocality, laparoscopic approach, pathological T-stage, presence of concomitant CIS and lymphovascular invasion were all associated with intravesical recurrence. On multivariable analysis, previous history of bladder cancer, tumor multifocality and laparoscopic approach remained independent predictors of intravesical recurrence. Existence of intravesical recurrence was not correlated with worst oncological outcomes in terms of disease recurrence (p = 0.075) and cancer-specific mortality (p = 0.06). CONCLUSIONS: In the current study, intravesical recurrence occurred in 35 % of patients with UTUC after RNU. Previous history of bladder cancer, tumor multifocality, concomitant CIS and laparoscopic approach were independent predictors of intravesical recurrence. These findings are in line with recent published data and should be considered carefully to provide a definitive surveillance protocol regarding management of urothelial carcinomas regardless of the location of urothelial carcinomas in the whole urinary tract.
OBJECTIVES: To identify predictive factors and assess the impact on oncological outcomes of intravesical recurrence after radical nephroureterectomy (RNU) in upper tract urothelial carcinoma (UTUC). METHODS: Using a national multicentric retrospective dataset, we identified all patients with UTUC who underwent a RNU between 1995 and 2010 (n = 482). Intravesical recurrence was tested as a prognostic factor for survival through univariable and multivariable Cox regression analysis. RESULTS: Overall, intravesical recurrence occurred in 169 patients (35 %) with a median age of 69.2 years (IQR: 60-76) and after a median follow-up of 39.5 months (IQR: 25-60). Actuarial intravesical recurrence-free survival estimates at 2 and 5 years after RNU were 72 and 45 %, respectively. On univariable analyses, previous history of bladder tumor, tumor multifocality, laparoscopic approach, pathological T-stage, presence of concomitant CIS and lymphovascular invasion were all associated with intravesical recurrence. On multivariable analysis, previous history of bladder cancer, tumor multifocality and laparoscopic approach remained independent predictors of intravesical recurrence. Existence of intravesical recurrence was not correlated with worst oncological outcomes in terms of disease recurrence (p = 0.075) and cancer-specific mortality (p = 0.06). CONCLUSIONS: In the current study, intravesical recurrence occurred in 35 % of patients with UTUC after RNU. Previous history of bladder cancer, tumor multifocality, concomitant CIS and laparoscopic approach were independent predictors of intravesical recurrence. These findings are in line with recent published data and should be considered carefully to provide a definitive surveillance protocol regarding management of urothelial carcinomas regardless of the location of urothelial carcinomas in the whole urinary tract.
Authors: Jeffery C Wheat; Alon Z Weizer; J Stuart Wolf; Yair Lotan; Mesut Remzi; Vitaly Margulis; Christopher G Wood; Francesco Montorsi; Marco Roscigno; Eiji Kikuchi; Richard Zigeuner; Cord Langner; Christian Bolenz; Theresa M Koppie; Jay D Raman; Mario Fernández; Pierre Karakiewizc; Umberto Capitanio; Karim Bensalah; Jean-Jacques Patard; Shahrokh F Shariat Journal: Urol Oncol Date: 2010-05-06 Impact factor: 3.498
Authors: Michael Rink; Harun Fajkovic; Eugene K Cha; Amit Gupta; Pierre I Karakiewicz; Felix K Chun; Yair Lotan; Shahrokh F Shariat Journal: Eur Urol Date: 2012-01-05 Impact factor: 20.096
Authors: Thomas J Walton; Giacomo Novara; Kazumasa Matsumoto; Wassim Kassouf; Hans-Martin Fritsche; Walter Artibani; Patrick J Bastian; Juan I Martínez-Salamanca; Christian Seitz; Stephen A Thomas; Vincenzo Ficarra; Maximilian Burger; Stefan Tritschler; Pierre I Karakiewicz; Shahrokh F Shariat Journal: BJU Int Date: 2010-11-15 Impact factor: 5.588
Authors: Morgan Rouprêt; Richard Zigeuner; Juan Palou; Andreas Boehle; Eero Kaasinen; Richard Sylvester; Marko Babjuk; Willem Oosterlinck Journal: Eur Urol Date: 2011-01-14 Impact factor: 20.096
Authors: Wolfgang Otto; Shahrokh F Shariat; Hans-Martin Fritsche; Amit Gupta; Kazumasa Matsumoto; Wassim Kassouf; Guido Martignoni; Thomas J Walton; Stefan Tritschler; Shiro Baba; Patrick J Bastian; Juan I Martínez-Salamanca; Christian Seitz; Armin Pycha; Maximilian Burger; Pierre I Karakiewicz; Vincenzo Ficarra; Giacomo Novara Journal: World J Urol Date: 2011-01-20 Impact factor: 4.226
Authors: Umberto Capitanio; Shahrokh F Shariat; Hendrik Isbarn; Alon Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Jay D Raman; Christian Bolenz; Karim Bensalah; Theresa M Koppie; Wassim Kassouf; Mario I Fernández; Philipp Ströbel; Jeffrey Wheat; Richard Zigeuner; Cord Langner; Matthias Waldert; Mototsugu Oya; Charles C Guo; Casey Ng; Francesco Montorsi; Christopher G Wood; Vitaly Margulis; Pierre I Karakiewicz Journal: Eur Urol Date: 2009-04-03 Impact factor: 20.096
Authors: Evanguelos Xylinas; Michael Rink; Eugene K Cha; Thomas Clozel; Richard K Lee; Harun Fajkovic; Evi Comploj; Giacomo Novara; Vitaly Margulis; Jay D Raman; Yair Lotan; Wassim Kassouf; Hans-Martin Fritsche; Alon Weizer; Juan I Martinez-Salamanca; Kazumasa Matsumoto; Richard Zigeuner; Armin Pycha; Douglas S Scherr; Christian Seitz; Thomas Walton; Quoc-Dien Trinh; Pierre I Karakiewicz; Surena Matin; Francesco Montorsi; Marc Zerbib; Shahrokh F Shariat Journal: Eur Urol Date: 2012-05-04 Impact factor: 20.096
Authors: Mounsif Azizi; Salim K Cheriyan; Charles C Peyton; Beat Foerster; Shahrokh F Shariat; Philippe E Spiess Journal: Curr Treat Options Oncol Date: 2019-04-01
Authors: Yang Hyun Cho; Young Ho Seo; Seung Jun Chung; Insang Hwang; Ho Song Yu; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Jun Eul Hwang; Suk Hee Heo; Geun Soo Kim; Eu Chang Hwang Journal: Korean J Urol Date: 2014-07-11